On June 9, 2017, Eurofins Scientific has acquired drug ingredient manufacturing and testing services firm Alphora Research Inc.
The deal, financial terms of which were not disclosed, will see Mississauga, Canada-based Alphora’s two facilities join Eurofins’ network of drug testing laboratories.
Alphora focuses on the production and testing of active pharmaceutical ingredients (APIs), including those made using multi-step syntheses, cytotoxics and highly potent ingredients. The firm employs approximately 100 people. Alphora is headquartered in Mississauga, Ontario.
Eurofins is an international group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental and consumer products industries and to governments.
Osler Hoskin & Harcourt LLP represented Alphora Research Inc. with a team led by Chad Bayne that included Brian Gray, Justin Dharamdial and Trevor Kirsh (Corporate) and Dov Begun (Tax).
Key Contact
Partner, Emerging and High Growth Companies, Toronto
Team
Partner, Corporate, Toronto
Partner, Emerging and High Growth Companies, Toronto
Partner, Tax, Toronto
